222551-17-9

Basic information

• Product Name: adoprazine
• Synonyms: adoprazine;1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-4-[[5-(4-fluorophenyl)-3-pyridinyl]methyl]piperazine;Unii-7snb18Q89d;SLV 313;SLV313;Adoprazine (SLV313)
• CAS NO: 222551-17-9
• Molecular Formula: C24H24FN3O2
• Molecular Weight: 405.46
• Mol File: 222551-17-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 565.0±50.0 °C(Predicted)
• Appearance: /
• Density: 1.256
• PKA: 6.07±0.10(Predicted)
• CAS DataBase Reference: adoprazine(CAS DataBase Reference)
• NIST Chemistry Reference: adoprazine(222551-17-9)
• EPA Substance Registry System: adoprazine(222551-17-9)

Safety Data

• Hazardous Substances Data: 222551-17-9(Hazardous Substances Data)

Usage

General Description

Adoprazine, also known as RP 73401, is a selective 5-HT1A receptor agonist and a member of the azapirone chemical class. It is primarily used as an anxiolytic and antidepressant, and has been studied for its potential in treating a range of psychiatric and neurological disorders. Adoprazine has shown promising results in clinical trials for treating anxiety disorders, depression, and schizophrenia, and it is believed to have fewer side effects than traditional anxiolytics and antidepressants. Its mechanism of action involves increasing the transmission of serotonin, a neurotransmitter known to affect mood and anxiety levels. Adoprazine is still under investigation and has not been approved for clinical use in most countries.